Achilles Therapeutics (ACHL)
NASDAQ: ACHL
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
Achilles Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 86.05M | 95.11M | 112.32M | 131.54M | 140.14M | 143.71M | 158.46M | 173.34M | 179.89M | 201.59M | 236.93M | 266.32M | 281.88M | 299.32M | 159.26M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 53K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | n/a | n/a |
Other Long-Term Assets | 1.78M | 2.2M | 2.17M | 2.21M | 3M | 3.19M | 3.17M | 3.05M | 2.75M | 3.02M | 3.67M | 3.54M | 3.4M | 3.24M | 3.15M |
Receivables | 21.79M | 18.35M | 15.73M | 10.35M | 9.6M | 23.03M | n/a | 16M | n/a | 17.13M | 14.46M | 11.17M | n/a | 11.96M | n/a |
Inventory | n/a | n/a | n/a | n/a | -9.6M | -23.03M | n/a | 4.62M | -10.71M | 5.96M | 4.25M | 5.13M | 6.27M | 8.1M | 3.92M |
Other Current Assets | 2.32M | 2.13M | 1.8M | 1.98M | 2.96M | 26.55M | 26.8M | 2.62M | n/a | 2.89M | 3.4M | 2.12M | n/a | 1.02M | 12.72M |
Total Current Assets | 111.63M | 117.82M | 131.43M | 145.63M | 155.49M | 175.21M | 185.26M | 196.58M | 198.69M | 227.58M | 259.05M | 284.75M | 298.28M | 320.4M | 173.32M |
Property-Plant & Equipment | 9.23M | 11.12M | 12.07M | 13.54M | 16.66M | 19.32M | 19.02M | 20.48M | 25.89M | 27.1M | 29.45M | 28.79M | 28.32M | 29.85M | 29.63M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | -33K | -33K | -33K | -33K | -33K | -33K | -33K | -33K | -33K | n/a | n/a |
Total Long-Term Assets | 11.05M | 13.37M | 14.31M | 15.82M | 19.85M | 22.7M | 22.37M | 23.78M | 28.66M | 30.14M | 33.14M | 32.36M | 31.72M | 33.09M | 32.78M |
Total Assets | 122.68M | 131.19M | 145.74M | 161.46M | 175.34M | 197.91M | 207.63M | 220.36M | 227.35M | 257.72M | 292.19M | 317.11M | 330M | 353.49M | 206.1M |
Account Payables | 4.25M | 2.87M | 3.31M | 5.63M | 5.35M | 6.89M | 7.65M | 5.19M | 7.52M | 6.65M | 4.04M | 3.72M | 2.46M | 6.05M | 1.79M |
Deferred Revenue | n/a | n/a | -3.31M | -5.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.64M | 6.59M | 6.3M | 7.42M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 7.34M | n/a | 1.14M | 965K | 965K | 12.05M | 9.08M | 1.75M | 12.44M | 18K | 2.34M | 1.98M | 36K | 2.24M | 1.95M |
Total Current Liabilities | 18.47M | 14.29M | 13.65M | 17M | 18.18M | 19.12M | 17.95M | 17.99M | 19.06M | 19.87M | 17.85M | 19.11M | 15.37M | 18.61M | 15.06M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.07M | 1.16M | 1.16M | 1.01M | 941K | 974K | 954K | 933K | 726K | 621K | 671K | 691K | 643K | 659K | 659K |
Total Long-Term Liabilities | 1.07M | 1.42M | 1.74M | 2.09M | 3.67M | 4.95M | 4.52M | 5.32M | 5.68M | 6.26M | 7.88M | 8.47M | 9.52M | 10.9M | 11.99M |
Total Liabilities | 19.54M | 15.71M | 15.39M | 19.09M | 21.85M | 24.06M | 22.46M | 23.31M | 24.73M | 26.13M | 25.73M | 27.58M | 24.89M | 29.52M | 27.05M |
Total Debt | 3.62M | 4.46M | 4.21M | 4.62M | 7.35M | 8.63M | 7.6M | 8.58M | 8.99M | 10.12M | 11.88M | 12.26M | 13.28M | 14.9M | 15.94M |
Common Stock | 54K | 182K | 182K | 182K | 54K | 54K | 54K | 54K | 54K | 54K | 54K | 54K | 54K | 54K | 6K |
Retained Earnings | -308.2M | -288.61M | -272.23M | -259.95M | -241.32M | -224.64M | -207.79M | -190.29M | -166.23M | -153.75M | -136.47M | -119.11M | -100.88M | -87.93M | -71.78M |
Comprehensive Income | -7.94M | -14.02M | -14.21M | -13.07M | -19.19M | -13.9M | -17.72M | -21.7M | -38.49M | -20.34M | -1.04M | 6.64M | 5.75M | 13.46M | 14.38M |
Shareholders Equity | 103.14M | 115.47M | 130.35M | 142.37M | 153.49M | 173.84M | 185.17M | 197.04M | 202.62M | 231.59M | 266.45M | 289.53M | 305.11M | 323.97M | 179.05M |
Total Investments | n/a | 53K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | 33K | n/a | n/a |